CIK 0001699031 · Non-accelerated filer<br>Emerging growth company
GRAIL, Inc.
Sign in to watch- Ticker
- GRAL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863673636
- Phone
- (833) 694-2553
- Business address
- 250 S. MATHILDA AVENUE, SUITE 100, SUNNYVALE, CA, 94086
- Former names
- GRAIL, LLC
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 31,055 shares (grant or award)
- 4 Grant or award Director acquired 210 shares (grant or award)
- 4 Grant or award Director acquired 248 shares (grant or award)
- 4 Grant or award Director acquired 296 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Grant or award Director acquired 978 shares (grant or award)
- 4 Grant or award Director acquired 1,656 shares (grant or award)
- 4 Grant or award Director acquired 1,054 shares (grant or award)
- 4 Open-market sale Chief Executive Officer sold 123,454 shares at $14.02 ($1,730,825)
- 144 Insider Sale of Securities
- 4 Open-market buy 10% owner bought 78,829 shares at an average $13.00 ($1,024,698)
- 3 Insider Initial Statement of Ownership
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Grant or award Chief Executive Officer acquired 260,080 shares (grant or award)
- 4 Grant or award President acquired 259,780 shares (grant or award)
Page 10 of 14 · 267 filings